Skip to content

Evaluation on the Effects of Two Rehabilitation Treatment and Tape for Functional and Motor Recovery of LBP Patients

Evaluation the Effectiveness of Two Modes of Rehabilitation Treatment and Elastic Taping for the Functional and Motor Recovery of the Patient Suffering From Low Back Pain.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05419310
Acronym
LBPT001
Enrollment
120
Registered
2022-06-15
Start date
2022-05-12
Completion date
2025-03-30
Last updated
2023-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Core Strengthening, Low Back Pain, Orthopedic Disorder, Physical Therapy, Rehabilitation

Keywords

Low Back Tape, Tape, Kinesio Tape, Core Strengthening, Pilates Rehabilitation, Physical Therapy, Athletic Tape

Brief summary

The objective of this study is to verify which is the most effective type of rehabilitation treatment (rehabilitation based on core strengthening vs pilates) in patients suffering from low back pain. The secondary objective is to verify whether the use of Kinesio Tape (KT) associated with rehabilitation treatment can have greater effects in the motor and functional recovery of patients suffering from Low Back Pain than traditional rehabilitation.

Detailed description

Patients will undergo an initial assessment with the Physical Medicine and Rehabilitation Unit Physicians, during which the participants will sign the informed consent. After that a first evaluation will be carried out (T-1) during which the subjects will be asked to perform 10 consecutive sit-to-stand tests and 10 consecutive front bending tests. During the sit-to-stand and front bending tests, the kinematics of the spine will be recorded using two MIMU - XSENS DOT. The following scales will also be administered: * Roland and Morris Disability Questionnaire * Numerical Rating Scales (NRS) 11-point scale to assess the average intensity of pain during the last week * The Short Form Health Survey 36 (SF-36) questionnaire to assess quality of life * The Modified Somatic Perception Questionnaire (MSPQ) to assess pain somatization * The Hospital Anxiety and Depression Scale (HADS) scale to assess anxiety and depression * The Pain Catastrophizing Scale (PSC) to assess the catastrophization of pain * The Pain Self-Efficacy Questionnaire (PSEQ) for multidimensional pain assessment * The Fear Avoidance Beliefs Questionnaire (FABQ) to assess pain avoidance beliefs Patients will be randomized in 2 groups (Group A and Group B). For both groups there will be 12 treatment sessions, 3 times a week. (4 weeks) At mid-treatment (after 2 weeks), at the end of treatment (T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5) the same assessments of the first visit will be repeated.

Interventions

OTHERRehabilitation - core strengthening

Physical rehabilitation based on core strengthening

OTHERRehabilitation - rehabilitation pilates

Physical rehabilitation based on rehabilitation pilates

OTHERElastic taping application

Application of elastic taping

Sponsors

Campus Bio-Medico University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Signing of informed consent * Chronic low back pain defined as non-specific self-reported low back pain that persists daily for at least 3 months or at least half of the days in the last 6 months.

Exclusion criteria

* Specific cause of low back pain: disc herniation, spinal stenosis, cauda equina syndrome, infection, fracture, tumor. * Pregnant women * Neurological disorders and neurological signs (e.g. CNS disorders, weakness, paresthesia) * Respiratory disorders * Previous spinal surgery. * Pain in the lower limbs or lesions limiting their function * Taking pain medication

Design outcomes

Primary

MeasureTime frameDescription
changes in the low back pain related disabilityAt mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)changes from baseline of the low back pain disability will be assessed through the use of the Roland and Morris Disability Questionnaire
changes in the low back pain intensity and perceptionAt mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)changes from baseline of the intensity of low back pain will be assessed through the use of the Numerical Rating Scale (NRS), the Modified Somatic Perception Questionnaire (MSPQ), the Pain Catastrophizing Scale (PCS), the Pain Self-Efficacy Questionnaire (PSEQ) and the Fear Avoidance Beliefs Questionnaire (FABQ)
changes in the low back pain related anxiety and depressionAt mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)changes from baseline of the low back pain related anxiety and depression will be assessed through the use of the Hospital Anxiety and Depression Scale (HADS)
changes in the spine kinematicsAt mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)changes from baseline of the low back pain kinematic will be assessed through the use of two MIMU - XSENS DOT. Subjects will be asked to perform 10 consecutive sit-to-stand tests and 10 consecutive front bending tests. During the tests, the kinematics of the spine will be recorded.

Secondary

MeasureTime frameDescription
changes in the low back pain related quality of lifeAt mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)changes from baseline of the low back pain related quality of life will be assessed through the use of the Short Form ealthSurvey 36 (SF-36)

Countries

Italy

Contacts

Primary ContactMarco Bravi, Dott
m.bravi@policlinicocampus.it0622541624

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026